Continuous glucose monitoring and long-term diabetes outcomes in Veterans
Official title: Use of continuous glucose monitoring and long-term diabetes outcomes within the Veteran Affairs Health Care System
Funded at Phoenix VA Health Care System · NIH-11213981 · Data updated 2026-11-12
This project looks at whether giving Veterans with type 1 or type 2 diabetes continuous glucose monitors is linked to better long-term outcomes like kidney and heart health and survival.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phoenix VA Health Care System NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project start | October 1, 2023 |
| Project end | September 30, 2027 |
| Funding year | 2026 |
| NIH project number | 5I01BX006126-03 |
| Project ID | NIH-11213981 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are Veterans with type 1 or type 2 diabetes who receive care within the VA health system and either use or are eligible to start continuous glucose monitoring.
✕Less likely to help
People without diabetes, those not receiving VA care, or Veterans whose diabetes is well-controlled without CGM may not gain direct benefit from this project.
What this research studies
If you are a Veteran with diabetes, the team will use VA medical records to see how starting continuous glucose monitoring (CGM) changes short-term blood sugar control and longer-term problems. They will pull clinical and demographic data for people with later-onset type 1 and type 2 diabetes and compare those who begin CGM to similar patients who do not. The researchers will follow outcomes such as kidney disease, heart disease, hospital events, and death across many years of VA care. They will also look at the time, costs, and staff effort needed to put CGM into routine care.
Why it matters
Potential benefit: If successful, this work could show which Veterans get real health gains from CGM and help guide who should be offered it in routine VA care.
How similar studies have gone: Short-term trials in early-onset type 1 diabetes have shown CGM lowers glucose and reduces hypoglycemia, but CGM benefits in later-onset type 1 and the much more common type 2 diabetes, and effects on long-term complications, are less well studied.
Where this research is happening
-
Phoenix VA Health Care System
Phoenix, United States Active
Researchers
- Principal investigator: Reaven, Peter D — Phoenix VA Health Care System
- Study coordinator: Reaven, Peter D
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.